Emily Dunn

2.2k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Emily Dunn is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Emily Dunn has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in Emily Dunn's work include HER2/EGFR in Cancer Research (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Emily Dunn is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Emily Dunn collaborates with scholars based in United States, Australia and United Arab Emirates. Emily Dunn's co-authors include Deric L. Wheeler, Paul M. Harari, Mari Iida, Amol J. Ghia, Daniel G. Petereit, Eric A. Armstrong, Kristin Bradley, Vinai Gondi, Meghan Nechrebecki and Tim J. Kruser and has published in prestigious journals such as Oncogene, International Journal of Radiation Oncology*Biology*Physics and Nature Reviews Clinical Oncology.

In The Last Decade

Emily Dunn

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Understanding resistance to EGFR inhibitors—impact on future treatment strategies

2010 540 citations Deric L. Wheeler, Emily Dunn et al. Nature Reviews Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Dunn United States	13	873	741	492	220	204	24	1.7k
Julia Wilkerson United States	20	608 0.7×	501 0.7×	713 1.4×	284 1.3×	208 1.0×	44	1.8k
Jermaine Coward Australia	23	1.2k 1.4×	704 1.0×	380 0.8×	354 1.6×	126 0.6×	87	2.3k
Stephen Welch Canada	24	1.0k 1.2×	626 0.8×	388 0.8×	279 1.3×	105 0.5×	124	1.9k
Marta Gil-Martín Spain	20	1.2k 1.4×	629 0.8×	526 1.1×	322 1.5×	324 1.6×	108	2.0k
Paula R. Pohlmann United States	22	1.3k 1.5×	655 0.9×	535 1.1×	489 2.2×	321 1.6×	100	2.3k
Anthony Kong United Kingdom	27	825 0.9×	561 0.8×	361 0.7×	193 0.9×	397 1.9×	73	1.8k
Mayu Yunokawa Japan	25	1.1k 1.3×	511 0.7×	482 1.0×	373 1.7×	312 1.5×	140	2.1k
Thibault De La Motte Rouge France	21	479 0.5×	692 0.9×	495 1.0×	329 1.5×	164 0.8×	99	1.7k
Sharad Ghamande United States	22	770 0.9×	579 0.8×	230 0.5×	216 1.0×	127 0.6×	114	1.7k
Gunnar Wagenius Sweden	23	873 1.0×	417 0.6×	600 1.2×	164 0.7×	101 0.5×	80	1.5k

Countries citing papers authored by Emily Dunn

Since Specialization

Citations

This map shows the geographic impact of Emily Dunn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Dunn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Dunn more than expected).

Fields of papers citing papers by Emily Dunn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Dunn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Dunn. The network helps show where Emily Dunn may publish in the future.

Co-authorship network of co-authors of Emily Dunn

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Dunn. A scholar is included among the top collaborators of Emily Dunn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Dunn. Emily Dunn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dunn, Emily, et al.. (2023). Molecular testing in newborn screening: VUS burden among true positives and secondary reproductive limitations via expanded carrier screening panels. Genetics in Medicine. 26(4). 101055–101055. 9 indexed citations

Brower, Jeffrey V., Jill Remick, Emily Dunn, et al.. (2023). Effect of COVID-19 on Gynecologic Oncology Care: A Survey of Practicing Gynecologic Radiation Oncologists in the United States. Advances in Radiation Oncology. 8(4). 101188–101188. 4 indexed citations

Williams, Vonetta M., Jenna M. Kahn, Matthew M. Harkenrider, et al.. (2020). COVID-19 impact on timing of brachytherapy treatment and strategies for risk mitigation. Brachytherapy. 19(4). 401–411. 34 indexed citations

Dunn, Emily, et al.. (2020). Evaluating an Ultraviolet C System for Use During SARS-CoV2 Pandemic and Personal Protective Equipment Shortage. Advances in Radiation Oncology. 6(2). 100636–100636. 6 indexed citations

Crilly, Richard J., et al.. (2020). Ultraviolet Germicidal Irradiation to Decontaminate Filtering Face Piece Respirators During COVID-19 Pandemic.. PubMed. 73(5). 212–216. 2 indexed citations

Brereton, Christopher J., et al.. (2018). Is gentamicin safe and effective for severe community-acquired pneumonia? An 8-year retrospective cohort study. International Journal of Antimicrobial Agents. 51(6). 862–866. 7 indexed citations

Brand, Toni M., Mari Iida, Emily Dunn, et al.. (2014). Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 13(5). 1356–1368. 40 indexed citations

Dunn, Emily, Heather M. Geye, Vinai Gondi, et al.. (2014). Predictive factors of recurrence following adjuvant vaginal cuff brachytherapy alone for stage I endometrial cancer. Gynecologic Oncology. 133(3). 494–498. 17 indexed citations

Shaverdian, Narek, et al.. (2013). Effects of Treatment Duration During Concomitant Chemoradiation Therapy for Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 86(3). 562–568. 45 indexed citations

10.

Gondi, Vinai, Søren M. Bentzen, Emily Dunn, et al.. (2012). Severe Late Toxicities Following Concomitant Chemoradiotherapy Compared to Radiotherapy Alone in Cervical Cancer: An Inter-era Analysis. International Journal of Radiation Oncology*Biology*Physics. 84(4). 973–982. 93 indexed citations

11.

Brand, Toni M., Emily Dunn, Mari Iida, et al.. (2011). Erlotinib is a viable treatment for tumors with acquired resistance to cetuximab. Cancer Biology & Therapy. 12(5). 436–446. 12 indexed citations

12.

Wheeler, Deric L., Emily Dunn, & Paul M. Harari. (2010). Understanding resistance to EGFR inhibitors—impact on future treatment strategies. Nature Reviews Clinical Oncology. 7(9). 493–507. 540 indexed citations breakdown →

13.

Li, Chunrong, Mari Iida, Emily Dunn, & Deric L. Wheeler. (2010). Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma. Radiotherapy and Oncology. 97(2). 330–337. 47 indexed citations

14.

Dunn, Emily, et al.. (2010). Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Oncogene. 30(5). 561–574. 109 indexed citations

15.

Iida, Mari, et al.. (2009). Nuclear EGFR contributes to acquired resistance to cetuximab. Oncogene. 28(43). 3801–3813. 249 indexed citations

16.

Wheeler, Deric L., Tim J. Kruser, Meghan Nechrebecki, et al.. (2009). Epidermal Growth Factor Receptor cooperates with Src Family Kinases in acquired resistance to cetuximab. Cancer Biology & Therapy. 8(8). 696–703. 118 indexed citations

17.

Dunn, Emily, Kevin R. Kozak, & John S. Moody. (2009). External Beam Radiotherapy for Colon Cancer: Patterns of Care. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1420–1424. 6 indexed citations

18.

Dunn, Emily, Mari Iida, Eric A. Armstrong, & Deric L. Wheeler. (2009). Abstract C43: Dasatinib resensitizes Kras mutant colorectal tumors to cetuximab. Molecular Cancer Therapeutics. 8(12_Supplement). C43–C43. 1 indexed citations

19.

Ahmed, Mohamed H., et al.. (1999). The translation into arabic and revalidation of a fatigue questionnaire. Eastern Mediterranean Health Journal. 5(3). 503–514. 10 indexed citations

20.

Dunn, Emily. (1987). The impact of technology and improved perioperative management upon survival from carcinoma of the pancreas.. PubMed. 164(3). 237–44. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact